William Blair & Company
ADAP

William Blair & Company’s Adaptimmune Therapeutics ADAP Stock Holding History

William Blair & Company’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40,000
Closed -$207K – 1962
2021
Q3 		$207K Buy
+40,000
New +$207K ﹤0.01% 1482